>>Signaling Pathways>> Others>>GCN2-IN-1 (A-92)

GCN2-IN-1 (A-92) (Synonyms: A-92, GCN2 Inhibitor 1, General Control Nonderepressible 2 Kinase Inhibitor 1)

Catalog No.GC32771

GCN2-IN-1(A-92)(A-92)은 효소 분석에서 IC50이 <0.3 μM이고 IC50이 0.3-3 777787888인 강력한 일반 대조군 비억제성 2 키나제(GCN2) 억제제입니다. 세포 분석에서.

Products are for research use only. Not for human use. We do not sell to patients.

GCN2-IN-1 (A-92) Chemical Structure

Cas No.: 1448693-69-3

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$212.00
재고 있음
5mg
US$193.00
재고 있음
10mg
US$304.00
재고 있음
25mg
US$607.00
재고 있음
50mg
US$1,011.00
재고 있음
100mg
US$1,747.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

GCN2-IN-1 is an inhibitor of general control nonderepressible 2 kinase (GCN2; IC50 = ~0.2 μM for autophosphorylation), a serine/threonine protein kinase involved in the integrated stress response.1 It also inhibits integrase phosphorylation (IC50 = ~0.2 μM for the HIV-1 enzyme). GCN2-IN-1 inhibits ELAV-like protein 1, also known as human antigen R (HuR), protein dimerization (IC50 = 4.5 μM).2 GCN2-IN-1 also decreases the viability of U251, XD456, U87, and LN-229 glioma cells (IC50s = 4.7, 2.8, 3.2, and 2.7 μM, respectively).

References:
1.Torres, C., Garling, A., Taouji, S., et al.Targeting the integrated stress response kinase GCN2 to modulate retroviral integrationMolecules26(17)5423(2021)
2.Filippova, N., Yang, X., Ananthan, S., et al.Targeting the HuR oncogenic role with a new class of cytoplasmic dimerization inhibitorsCancer Res.81(8)2220-2233(2021)

리뷰

Review for GCN2-IN-1 (A-92)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GCN2-IN-1 (A-92)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.